The largest community of pharma leaders

David Hicks, M.D. Named Chief Executive Officer of Turner Scientific

JACKSONVILLE, Ill.–()–Turner Scientific, a world leader in nonclinical hearing research, has named David Hicks, M.D. as Chief Executive Officer. Dr. Hicks, formerly Turner Scientific’s business development manager for contract research, will continue to oversee marketing of the company’s research operations. He will also assume responsibility for development of the company’s noise and vibration monitoring services, corporate strategy, human resources, and financial operations.

“We are very excited to promote David to the role of CEO,” said Turner Scientific’s Chief Scientific Officer and founder, Jeremy Turner, PhD. “This is a very promising time for Turner Scientific, as we have also hired two scientists to complement our research staff, and are planning in imminent move to a much larger research facility. David’s leadership, and his understanding of the consequences of hearing loss and tinnitus, make him an excellent choice to guide this continued growth.”

With experience in both clinical hearing disorders and nonclinical auditory science, Dr. Hicks is excited to bridge these disciplines while collaborating with biotechnology companies, pharmaceutical companies, and academic labs. “Dr. Turner has dedicated his career to studying the ears, and has assembled a team of auditory researchers that is unmatched by any other contract research organization,” he says. “It is a privilege to lead this team. This is a period of rapid innovation for hearing treatments, and I greatly enjoy being a part of this growth.”

Prior to Turner Scientific, Dr. Hicks served as Director of Clinical and Business Operations at Fortuna Fix, Inc., and Vice President of Fleetridge Pacific, a healthcare mergers and acquisitions advisory firm. As a medical doctor, he received training in ear-related disorders during his residency in otolaryngology.

About Turner Scientific

Turner Scientific is a nonclinical contract research organization specializing in auditory sciences, and a consultant in noise and vibration control to animal research facilities. The company offers a full range of auditory testing methods, including behavioral audiometry, tinnitus testing, auditory brainstem response testing, cytocochleograms, ribbon synapse analysis, and cochlear explant studies. Efficacy studies are conducted for leading biotechnology companies, pharmaceutical companies, and academic labs developing novel treatments for the ears. Ototoxicity analysis is provided for developers of drugs and manufacturers of industrial chemicals. Turner Scientific is also a leading provider of consultancy and monitoring services to minimize the confounding influences of noise and vibration exposure of animals in research facilities.

Read More


Recent Articles

Face Masks Disrupting Effective Communication for Those With Hearing Loss

MINNEAPOLIS--(BUSINESS WIRE)--The COVID-19 pandemic continues to change the way we all...

Packaging Technology Group (PTG) Completes Its Line of Thermally Pre-Qualified 2-8°C Shipping Solutions for Vaccines and Biologics

BOSTON--(BUSINESS WIRE)--Packaging Technology Group, Inc (PTG), a leading provider of thermal...

Gilead Sciences Update on Supply and Distribution of Veklury® (remdesivir) in the United States

FOSTER CITY, Calif.--(BUSINESS WIRE)--Since the COVID-19 pandemic began, Gilead has worked...

JEOL Strengthens European Business in the Medical Equipment Segment

TOKYO--(BUSINESS WIRE)--JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) has opened...

Thomas Health Emerges From Bankruptcy, Keeps Hospitals Open

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--At a time when hospitals are hardest hit,...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.